Correlation Between Lower Lobe Dose Parameters and Radiation Pneumonitis in Definitive Radiation Therapy for Non‐Small Cell Lung Cancer
Open Access
- 19 August 2026
- journal article
- research article
- Published by Wiley in Thoracic Cancer
- Vol. 17 (16) , e70369
Abstract
Background: This study examined whether lobar‐specific dose‐volume histogram (DVH) parameters add predictive information for radiation pneumonitis (RP) beyond conventional whole‐lung parameters in patients with non‐small cell lung cancer (NSCLC) undergoing definitive radiotherapy. Methods: We retrospectively analyzed 145 NSCLC patients treated between 2018 and 2023. Conventional whole‐lung parameters, including V5%, V20%, and mean lung dose (MLD), lobar‐specific parameters, including Low V20% (percentage of the bilateral lower lobes receiving ≥ 20 Gy), and clinical parameters were analyzed. The predictive performance of each parameter for Grade ≥ 2 RP was evaluated using receiver operating characteristic curve analysis. Associations with Grade ≥ 2 RP were assessed by Gray test and Fine‐Gray competing risks regression. Results: Grade ≥ 2 RP had an incidence of 41% (60/145) and showed significant associations with V20% ( p = 0.005), MLD ( p = 0.025), Low V5% ( p = 0.006), and Low V20% ( p = 0.003). In multivariate analysis, a high Brinkman Index (BI) (HR = 2.10, 95% CI: 1.27–3.48, p = 0.004) and high Low V20% (HR = 2.31, 95% CI: 1.12–4.74, p = 0.023) were independent predictors for Grade ≥ 2 RP. The correlation between V20% and Low V20% was moderate ( r = 0.505), with minimal multicollinearity (variance inflation factor 1.34). Conclusion: Low V20% was independently associated with Grade ≥ 2 RP and may provide complementary information to conventional whole‐lung DVH parameters and BI. This simple lobar‐specific parameter may help refine pretreatment RP risk stratification, although external validation is required before its incorporation into individualized planning constraints.Keywords
This publication has 18 references indexed in Scilit:
- Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLCJTO Clinical and Research Reports, 2024
- Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective studyRadiotherapy and Oncology, 2021
- Lobar distribution of non-emphysematous gas trapping and lung hyperinflation in chronic obstructive pulmonary diseaseRespiratory Investigation, 2020
- Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Regional variability in radiation-induced lung damage can be predicted by baseline CT numbersRadiotherapy and Oncology, 2017
- A Voxel-Based Approach to Explore Local Dose Differences Associated With Radiation-Induced Lung DamageInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Dose–volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapyRadiotherapy and Oncology, 2009
- Radiation pneumonitis and fibrosis: Mechanisms underlying its pathogenesis and implications for future researchInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Regional differences in lung radiosensitivity after radiotherapy for non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004